MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • MDS Virtual Congress 2020

    Speech is a sensitive marker in premanifest Huntington’s disease: exploring acoustic, cognitive and fine motor performance

    A. Vogel, J. Chan, Y. Lie, J. Stout (Melbourne, Australia)

    Objective: To explore the utility of objective analysis of speech as a quantifiable clinical biomarker in premanifest HD. Background: The autosomal dominant inheritance of Huntington’s…
  • MDS Virtual Congress 2020

    Subjective Cognitive Complaints in early Parkinson’s Disease patients with normal cognition are associated with affective symptoms

    C.Y Chua, M.E Koh, N.Y Chia, S.E Ng, S.E Saffari, M.C Wen, R.Y Chen, X. Choi, D.L Heng, S.X Neo, K.Y Tay, W.L Au, E.K Tan, L.S Tan, Z. Xu (Singapore, Singapore)

    Objective: To determine the prevalence of Subjective Cognitive Complaints (SCC) in early Parkinson’s disease (PD) and examine the correlates between SCC in early PD and…
  • MDS Virtual Congress 2020

    Alexithymia, Depression, and Cognition in Patients with Parkinson’s disease

    G. Kenangil, M. Demir, E. Tur, F. Domaç (Istanbul, Turkey)

    Objective: The aim of our study is to examine the relation of alexithymia with cognition and depression in non-demented patients with Parkinson's disease (PD). Background:…
  • MDS Virtual Congress 2020

    Parkinson’s Disease Clinical Subtypes: Symptom Progression, Dementia, and Mortality

    P. Myers, J. Jackson, A. Clover, C. Lessov-Schlaggar, E. Foster, J. Perlmutter, M. Campbell (St. Louis, MO, USA)

    Objective: Identify Parkinson's disease (PD) clinical subtypes using multi-domain classification; determine subtype symptom progression; assess subtype clinical utility. Background: People with PD present with combinations…
  • MDS Virtual Congress 2020

    Investigating Factors Contributing to Parkinson’s disease-related Cognitive Decline

    P. Tipton, N. Bulbul, J. Crook, O. Ross, Z. Wszolek, N. Ertekin-taner (Jacksonville, FL, USA)

    Objective: The objective of this study was to identify predictive factors of cognitive decline in patients with Parkinson’s disease (PD). Background: Among those with PD,…
  • MDS Virtual Congress 2020

    Nucleus basalis of Meynert free-water distinguishes and predicts cognitive impairment and longitudinally correlates with cognitive changes in early Parkinson’s disease

    T. Guttuso, Jr., D. Tosun, R. Zivadinov, O. Pasternak, D. Weintraub, N. Bergsland (Buffalo, NY, USA)

    Objective: To explore diffusion-based MRI assessments of the nucleus basalis of Meynert (nbM) as a neuroimaging biomarker of cognitive abilities and longitudinal cognitive changes in…
  • MDS Virtual Congress 2020

    Is the Montreal Cognitive Assessment (MoCA) Suitable for Identifying Mild Cognitive Impairment in Parkinson’s Disease?

    S. Hassin-Baer, S. Meyer, N. Gemerman, L. Mentzer, S. Israeli-Korn, A. Richardson, V. Livneh, T. Fay Karmon, T. Nevo, H. Strauss, G. Yahalom, S. Rosenblum (Ramat-Gan, Israel)

    Objective: To explore neuropsychological test scores of Parkinson’s disease (PD) patients who were categorized based on their Montreal Cognitive Assessment (MoCA) scores as having mild…
  • MDS Virtual Congress 2020

    Visuospatial training improved the visuospatial abilities in child with cerebral palsy: case report

    S. Kiselev (Ekaterinburg, Russian Federation)

    Objective: The goal of this study was to assess the impact of 16 weeks of visuospatial training on the visuospatial abilities in 6 years of…
  • MDS Virtual Congress 2020

    Cognitive and functional predictors of ADL performance in persons with Parkinson’s Disease

    J. Rider, J. Longhurst, M. Landers (Las Vegas, NV, USA)

    Objective: To determine which commonly used cognitive screening tests were the best predictors of ADL performance in PD and to determine if additional functional and…
  • MDS Virtual Congress 2020

    Myoclonic epilepsy with ragged-red fibers: the first described clinical case in Ukraine

    Y. Trufanov, N. Svyrydova, A. Galusha, V. Sereda, V. Svistun, I. Zarashchak, A. Yanchak (Kyiv, Ukraine)

    Objective: To provide a description of a case of myoclonic epilepsy with ragged-red fibers (MERRF) diagnosed in Kyiv, Ukraine. Background: MERRF is a rare mitochondrial…
  • « Previous Page
  • 1
  • …
  • 71
  • 72
  • 73
  • 74
  • 75
  • …
  • 141
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley